The fentanyl controlled release patch Matrifen® with fentanyl eases your pain

The fentanyl controlled release patch Matrifen® from Nycomed helps releave pain in patients with severe chronic pain.

The fentanyl controlled release patch Matrifen® from Nycomed helps to ease severe chronic pain in patients with cancer, low back pain etc.

>> Information on the fentanyl controlled release patch

Matrifen with fentanyl controlled release provides pain relief to patients with prolonged or chronic severe pain. Following application of the patch to the skin, fentanyl is released into the systemic circulation by passive cutaneous diffusion.

Fentanyl has a high affinity for receptors located throughout the peripheral nervous system, the brain and the spinal cord, and binding to the receptors cause analgesia.

About Nycomed
Nycomed is a young company with a long history. Founded in 1874 in Norway by Morten Nyegaard, the company gradually began to expand into Europe, forming a strong position initially in the Nordic countries.

The modern story really begins in 1999, when Nycomed was established as a European company with a focus on sourcing and developing new pharmaceutical products. With this in place, the pace of this market expansion increased and the company now operates throughout Europe.

Cognitive impairment | Peripheral diabetic neuropathy | Opioid effects